National Cancer Institute, Research Contracts Branch, PSAS, 6120 Executive Blvd, EPS/Room 638, Bethesda, MD 20892-7227

66 -- GRIDDING ROBOT/ARRAYER SOL RFQ80083-NS DUE 022798 POC Patricia Haun, Contracting Officer (301) 496-8613 The National Cancer Institute (NCI) Division of Clinical Sciences plans to procure on a sole source basis under authority of FAR 6.302-1, a Gridding Robot/Arrayer from Gene Machines, 2992 Spring St. Unit A, Redwood City, CA 94063. The Gridding Robot/Arrayer is a state-of-the-art technology which allows researchers to screen hundreds to thousands of DNA, c-DNA, or RNA sequences at one time for the presence of particular genes, and quantitate and analyze this information. The technology will be linked to the NCI and Cancer Genome Anatomy Project (CGAP) initiative, enabling scientists to map the sequences differentially expressed by cancer cells and begin the process of determining the basis for the transformation of normal cells to malignant cells at the molecular level. This instrument will help the Division of Clinical Sciences identify and map all genes associated with human cancers. This specific design/innovation was built by Gene Machines and has been modified to improve the quality of the arrays produced and are exclusive developments of Gene Machine. This is the only vendor that NCI is aware of that is capable of constructing this instrument. This notice of intent is not a request for competitive proposals. However, all responsible parties that believe that they can meet the above requirements may submit capability statements. Information furnished shall include enough material, in sufficient detail, to allow NCI to perform a proper evaluation of their ability to perform. Materials must be received within 15 days of the publication of this notice (0043)

Loren Data Corp. http://www.ld.com (SYN# 0327 19980217\66-0013.SOL)